Pharma-Leaks

Big Pharma is pressuring Europe over drug prices. $PFE , $AZN , $LLY and others have warned Germany that pricing reforms could threaten investment, expansion plans and future drug launches. The industry says higher spending supports innovation and patient access. Critics warn that when health systems pay more for medicines, patients may lose funding elsewhere. Our latest examines the pharmaceutical industry’s UK playbook and the growing battle over who controls Europe’s healthcare budgets. Read more: pharma-leaks.com #PharmaLeaks #BigPharma #DrugPricing #Healthcare

Recent whistleblower allegations claim $ABT bribed a Hawaiʻi provider through free equipment, bundling and “prebate” deals. Abbott denies the claims. But this is not the first time $ABT has faced scrutiny. From its $1.5B Depakote settlement to a new PediaSure marketing lawsuit, the company’s conduct raises wider questions about medical marketing, kickbacks and patient trust. Read more: pharma-leaks.com #PharmaLeaks #Abbott #Healthcare #MedTech #Whistleblower #FalseClaimsAct

Big Pharma has spent decades selling the benefits. But patients also deserve the risks clearly, upfront and without fine print. From Vioxx and Bextra to Xarelto, Actos and opioid litigation, lawsuits and regulators have repeatedly exposed safety questions that patients often learned too late. The FDA’s crackdown on deceptive drug ads is a reminder: transparency should not depend on litigation. Read more: pharma-leaks.com #PharmaLeaks #BigPharma #FDA #DrugSafety #PatientSafety $PFE $MRK $JNJ $TAK $LLY

Big Pharma scandals are not just about corporate settlements. They are about leadership. From opioid lawsuits and multimillion dollar CEO bonuses to rare cases where pharma executives faced prison time, the question is simple: when patients, taxpayers and shareholders pay the price, why do executives so often keep cashing in? Read more: pharma-leaks.com #PharmaLeaks #BigPharma #Opioids #DrugPricing #CorporateAccountability

Big Pharma misconduct is often exposed because one insider decides silence is no longer an option. Whistleblowers like Lisa Pratta risked careers, income, health insurance, and personal safety to bring allegations of pharma fraud into the light. We do not just need to expose powerful companies. We need to support the people taking the risk to tell the truth. Read more: pharma-leaks.com #PharmaLeaks #BigPharma #Whistleblowers #FalseClaimsAct #Healthcare

Big Pharma scandals are not just about corporate settlements. They are about leadership. From opioid lawsuits and multimillion dollar CEO bonuses to rare cases where pharma executives faced prison time, the question is simple: when patients, taxpayers and shareholders pay the price, why do executives so often keep cashing in? Read more: pharma-leaks.com #PharmaLeaks #BigPharma #Opioids #DrugPricing #CorporateAccountability

Clinical trials are supposed to be the foundation of evidence-based medicine. But from allegations of manipulated data and selective reporting to concerns over ghostwriting, publication bias, and trial site misconduct, questions about transparency continue to shadow parts of the pharmaceutical industry. Our latest examines why clinical trial integrity remains one of healthcare's most important debates. Read more: pharma-leaks.com #Pharma #Biotech #ClinicalTrials

The FDA issued 25 warning letters to telehealth companies over allegedly misleading claims about compounded GLP-1 weight-loss drugs. But this story is bigger than compounded semaglutide. Over the past year, regulators have sent marketing violation letters to some of the pharmaceutical industry's biggest players, including Pfizer, Novartis, Eli Lilly, Novo Nordisk, AstraZeneca and Bristol Myers Squibb, as scrutiny of drug advertising intensifies. Our latest on the FDA's widening crackdown on pharmaceutical marketing and promotion 👇 pharma-leaks.com $LLY $NVO $PFE $NVS $AZN $BMY

Another whistleblower lawsuit. Another False Claims Act battle. Genentech and Novartis $NVS face allegations of kickback schemes linked to allergy drug prescriptions and federal healthcare programs. The case adds to a decades-long pattern of FCA investigations and settlements across Big Pharma, putting industry marketing practices back under the spotlight. Read more: pharma-leaks.com #Pharma #Biotech #Healthcare

The FDA banned overseas factories after inspectors found contamination risks, dirty labs, falsified records, and manipulated testing. Then it quietly allowed some drugs from those same factories into the U.S. anyway. ProPublica’s investigation raises a disturbing question: When regulators choose between shortages and quality, do patients ever get the full story? Read more: pharma-leaks.com #PharmaLeaks #GenericDrugs #FDA #PatientSafety

For decades, some of Big Pharma's biggest players, including $JNJ $PFE $TEVA $NVS $BMY, have faced bribery investigations tied to allegations of kickbacks, sham studies, consulting fees, luxury travel, and improper payments. The bigger issue isn't the fines. It's whether financial incentives have influenced prescribing, drug approvals, and healthcare decisions for years. Read more: pharma-leaks.com #BigPharma

The latest entry in the Pfizer $PFE Files examines the Trovan controversy in Nigeria, where questions over ethics, informed consent, and regulatory approval during a deadly meningitis epidemic sparked investigations, lawsuits, and years of controversy. Long after the drug disappeared, the debate over trust, transparency, and accountability remained. Read more here: pharma-leaks.com

Before the opioid crisis dominated headlines, one pharmaceutical sales rep raised concerns about the marketing of Actiq — a fentanyl-based "opioid lollipop" approved for breakthrough cancer pain. Bruce Boise later worked with investigators, lost his career, and became one of the most notable healthcare whistleblowers of the era. Years later, the case remains a reminder of how early warnings about opioid risks often came from insiders willing to speak up. Read more: pharma-leaks.com #PharmaLeaks #OpioidCrisis #Healthcare #Whistleblower #BigPharma

Americans pay the highest drug prices in the world. Meanwhile, Pfizer $PFE , Merck $MRK , Johnson & Johnson $JNJ , AbbVie $ABBV , Amgen $AMGN and Bristol Myers $BMY have faced scrutiny over offshore tax structures that allow profits from U.S. drug sales to be booked abroad. Big Pharma's favorite treatment? Tax avoidance. Read more here: pharma-leaks.com #PharmaLeaks #BigPharma #TaxJustice

For decades, Big Pharma didn't just sell medicines—it helped shape the science behind them. Research found industry-funded studies were significantly more likely to produce favorable results, while ghostwriting, publication bias, and selective reporting raised serious questions about the integrity of medical evidence. When corporations control the data, the research, and the narrative, can patients trust the science they're being sold? Read more: pharma-leaks.com #PharmaLeaks #BigPharma #PatientSafety

Americans are losing trust in Big Pharma. Years of drug pricing controversies, patent battles, marketing scandals, and healthcare affordability concerns have created fertile ground for movements like MAHA. But does skepticism of pharmaceutical companies justify trusting wellness influencers and supplement sellers? Our latest PharmaLeaks article explores the growing tension between Big Pharma's credibility crisis and the rise of Big Wellness. Read more: pharma-leaks.com

Johnson & Johnson $JNJ won another talc trial, with a jury rejecting claims that its baby powder caused ovarian cancer in three women. But while J&J may have secured a courtroom victory, the company remains tied to years of controversy spanning talc, opioids, product safety, and pharmaceutical conduct. Our latest PharmaLeaks piece examines the bigger picture. Read more here: pharma-leaks.com

A former Biogen $BIIB executive helped uncover an alleged kickback scheme that ended in a $900 million settlement. When a whistleblower earns $250 million for exposing conduct inside a pharma company, it raises a bigger question: How many similar practices never come to light? Read more here: pharma-leaks.com

A BBC undercover investigation has linked an Indian pharmaceutical manufacturer to the export of highly addictive opioid products now driving a public health crisis across parts of West Africa. The products were allegedly unlicensed, widely abused, and sold despite known risks. The opioid crisis is no longer just a Western story. Read our latest PharmaLeaks articles: pharma-leaks.com

The DOJ launched a new National Fraud Enforcement Division after unveiling more than $500M in alleged healthcare and COVID fraud schemes. The cases expose how taxpayer-funded healthcare programs can be exploited through fraudulent enrolments, billing schemes, and reimbursement abuse. As healthcare spending rises, so do questions about who is really benefiting from the system. Read more here: pharma-leaks.com